Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  799 نتائج ل ""Bronchodilator Agents""

فلترة النتائج

Subject : adrenergic beta-2 receptor agonists فلترة بواسطة : كلمات مفتاحية
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Prescription patterns and effectiveness of medications for chronic obstructive pulmonary disease: A retrospective study of real-world settings.

  • Authors : Park HJ; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Lee JU

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Muscarinic Antagonists*/Muscarinic Antagonists*/Muscarinic Antagonists*/administration & dosage ; Muscarinic Antagonists*/Muscarinic Antagonists*/Muscarinic Antagonists*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Jun 10; Vol. 19 (6), pp. e0304362. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.

  • Authors : Usmani O; Asthma Lab, National Heart and Lung Institute (NHLI), Imperial College London & Royal Brompton Hospital, South Block, Royal Brompton Campus, Sydney St, Chelsea, London, SW3 6NP, UK. .; Roche N

Subjects: Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/administration & dosage ; Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/adverse effects ; Bronchodilator Agents*/Bronchodilator Agents*/Bronchodilator Agents*/administration & dosage

  • Source: Respiratory research [Respir Res] 2021 Oct 07; Vol. 22 (1), pp. 261. Date of Electronic Publication: 2021 Oct 07.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.

  • Authors : Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Centre Giessen and Marburg, Philipps-Universität Marburg, German Centre for Lung Research (DZL), Baldingerstraße, 35043, Marburg, Germany. .; Jones PW

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Benzyl Alcohols/Benzyl Alcohols/Benzyl Alcohols/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

  • Source: Respiratory research [Respir Res] 2021 Oct 28; Vol. 22 (1), pp. 279. Date of Electronic Publication: 2021 Oct 28.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.

  • Authors : Zheng J; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Baldi S

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Beclomethasone/Beclomethasone/Beclomethasone/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

  • Source: Respiratory research [Respir Res] 2021 Mar 23; Vol. 22 (1), pp. 90. Date of Electronic Publication: 2021 Mar 23.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator.

  • Authors : Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, 08020, Barcelona, Spain. .; Astbury C

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Asthma/Asthma/Asthma/*drug therapy ; Bronchoconstriction/Bronchoconstriction/Bronchoconstriction/*drug effects

  • Source: Respiratory research [Respir Res] 2020 Sep 09; Vol. 21 (Suppl 1), pp. 211. Date of Electronic Publication: 2020 Sep 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies.

  • Authors : Balaguer V; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain.; Albayaty M

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage ; Muscarinic Antagonists/Muscarinic Antagonists/Muscarinic Antagonists/*administration & dosage

  • Source: Respiratory research [Respir Res] 2020 Sep 09; Vol. 21 (Suppl 1), pp. 212. Date of Electronic Publication: 2020 Sep 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator.

  • Authors : Singh D; The Medicines Evaluation Unit, Centre for Respiratory and Allergy Medicine, University of Manchester, University Hospital of South Manchester NHS Foundation Trust, M23 9QZ, Manchester, UK. .; Balaguer V

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Bronchoconstriction/Bronchoconstriction/Bronchoconstriction/*drug effects ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

  • Source: Respiratory research [Respir Res] 2020 Sep 09; Vol. 21 (Suppl 1), pp. 102. Date of Electronic Publication: 2020 Sep 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.

  • Authors : Dean J; Medicines Evaluation Unit, Southmoor Road, Manchester, M23 9QZ, UK. .; Panainte C

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Beclomethasone/Beclomethasone/Beclomethasone/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

  • Source: Respiratory research [Respir Res] 2020 Dec 09; Vol. 21 (1), pp. 323. Date of Electronic Publication: 2020 Dec 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.

  • Authors : Faiz A; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Subjects: Gene Expression Profiling*; Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*therapeutic use ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*therapeutic use

  • Source: Scientific reports [Sci Rep] 2020 Oct 15; Vol. 10 (1), pp. 17415. Date of Electronic Publication: 2020 Oct 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis.

  • Authors : Miravitlles M; Pneumology Department, Hospital Universitari Vall d'HebronVall d'Hebron Institut de Recerca, Vall d'Hebron Barcelona Hospital Campus, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain. .; García-Rivero JL

Subjects: Adrenergic beta-2 Receptor Agonists* ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy

  • Source: Respiratory research [Respir Res] 2022 Dec 15; Vol. 23 (1), pp. 347. Date of Electronic Publication: 2022 Dec 15.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  799 نتائج ل ""Bronchodilator Agents""